T
TuHURA Biosciences, Inc. (HURA)
NCM – Real Time Price. Currency in USD
2.16
-0.43 (-16.60%)
At close: Jun 26, 2026, 4:00 PM EDT
2.23
+0.07 (3.15%)
After-hours: Jun 26, 2026, 7:33 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.16
-0.43 (-16.60%)
At close: Jun 26, 2026, 4:00 PM EDT
2.23
+0.07 (3.15%)
After-hours: Jun 26, 2026, 7:33 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $6.3M significantly exceed its total debt $456.9K, ensuring strong financial flexibility
Total current assets $7.0M exceed Total current liabilities $6.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-269.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.15 | 6.05 | 7.0 | |
| Quick ratio | 1.15 | 5.63 | 7.0 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | -269.17 | -16.91 | 1.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -60K | -60K | -117K | -71K | -81K |
| Operating Income | -23M | -15M | -18M | -28M | -29M |
| Net Income | -23M | -15M | -22M | -30M | -31M |
| EBITDA | -23M | -15M | -18M | -28M | -29M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 26.98 | 5.5 |
| Next quarter | N/A | 4.76 | 2.5 |
| Current year | N/A | 11.11 | 4.0 |
| Next year | N/A | -0.6 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -11.46 | -3.99 | 20.09 | 5.5 |
| Y/Y | 999 | -13.08 | 13.33 | 6.68 | 6.0 |
| 3y average | 999 | -17.07 | 85.09 | -22.96 | 5.5 |
| 5y average | 999 | -66 | 47.78 | -42.98 | 5.5 |
| Weighted average score | 5.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |